Literature DB >> 20598036

Risk factors for complications in patients undergoing myomectomy at the time of cesarean section.

Yun-Sook Kim1, Seung-Do Choi, Dong-Han Bae.   

Abstract

AIM: The aim of this study was to evaluate the risk factors for complications of myomectomy at cesarean section (CS).
METHODS: The subjects were a non-complicated group (n = 100) and a complicated group (n = 10) of patients aged between 20 and 43 years who underwent CS and simultaneous myomectomy at our institution from January 2006 until December 2008. Complications were defined as blood transfusion greater than three packed red blood cells, postoperative ileus, and two days longer than average hospitalization.
RESULTS: The complicated group (n = 10) had (i) a myoma larger than 10 cm and no secondary change; and (ii) intramural myoma type.
CONCLUSION: Myomectomy during CS can be performed in selected cases, but some patients had significant complications like ileus and postoperative atonic bleeding.

Entities:  

Mesh:

Year:  2010        PMID: 20598036     DOI: 10.1111/j.1447-0756.2010.01195.x

Source DB:  PubMed          Journal:  J Obstet Gynaecol Res        ISSN: 1341-8076            Impact factor:   1.730


  4 in total

1.  The evaluation of myomectomies performed during cesarean section in our clinic.

Authors:  Kadı Celal; Cıçek Hülya
Journal:  Niger Med J       Date:  2011-07

2.  Outcomes of Myomectomy at the Time of Cesarean Section among Pregnant Women with Uterine Fibroids: A Retrospective Cohort Study.

Authors:  Rong Zhao; Xin Wang; Liying Zou; Weiyuan Zhang
Journal:  Biomed Res Int       Date:  2019-03-10       Impact factor: 3.411

3.  Outcome of Cesarean Myomectomy: Is it a Safe Procedure?

Authors:  Mehmet Baki Senturk; Mesut Polat; Ozan Doğan; Çiğdem Pulatoğlu; Oğuz Devrim Yardımcı; Resul Karakuş; Ahter Tanay Tayyar
Journal:  Geburtshilfe Frauenheilkd       Date:  2017-11-27       Impact factor: 2.915

4.  Use of the base purse-string suture approach to remove giant uterine fibroids during cesarean section.

Authors:  Dan Liu; Min Han; Pu Huang; Chunfang Li; Xuelan Li
Journal:  J Int Med Res       Date:  2019-12-31       Impact factor: 1.671

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.